FDA Inspection
Avista Pharma Solutions, Inc. dba CambrexAvista Pharma Solutions, Inc. dba Cambrex – FDA Inspection, Nov 9, 2018
Record Details
This FDA Inspection record concerns Avista Pharma Solutions, Inc. dba Cambrex, with an inspection on November 9, 2018, issued by the Denver District Office, covering human drugs.
- Inspection Date
- November 9, 2018
- Product Type
- Human Drugs
View Company Profile
ID · 351ce4fd-8083-4249-973f-dd508cc0bde1
Inspection Facts
- Inspection number
- 1072967
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of Avista Pharma Solutions, Inc. dba Cambrex
1| Date | Classification | Office | Project area |
|---|---|---|---|
| May 3, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Avista Pharma Solutions, Inc. dba Cambrex
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.